Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:56 AM
Ignite Modification Date:
2025-12-25 @ 4:56 AM
NCT ID:
NCT03773718
Eligibility Criteria:
Inclusion Criteria:
* Cancer survivors:
* Treatment with chemotherapy and/or radiation therapy for a primary ALL/NHL diagnosed prior to age 17 years.
* ≤ 15 years of age at the time of enrollment.
* No cytostatic drugs uptake during the study.
Exclusion Criteria:
* Diagnosis of diabetes mellitus types 1 or 2 types before antitumor therapy
* Active oncological disease
* History of allogeneic hematopoietic cell transplant
* The renouncement of participation from the patient or legally authorized representative
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
15 Years
Study:
NCT03773718
Study Brief:
Protocol Section:
NCT03773718